Open AccessDiagnosis and Treatment of Pelvic Inflammatory Disease
Author(s) -
Catherine L. Haggerty,
Roberta B. Ness
Publication year - 2008
Publication title -
women's health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.363
H-Index - 39
eISSN - 1745-5065
pISSN - 1745-5057
DOI - 10.2217/17455057.4.4.383
Subject(s) - pelvic inflammatory disease , medicine , etiology , azithromycin , chlamydia trachomatis , ectopic pregnancy , antibiotics , neisseria gonorrhoeae , disease , regimen , intensive care medicine , immunology , surgery , pregnancy , biology , genetics , microbiology and biotechnology
Pelvic inflammatory disease (PID), the infection and inflammation of the female upper genital tract, is a common cause of infertility, chronic pain and ectopic pregnancy. Diagnosis and management are challenging, largely resulting from varying signs and symptoms and a polymicrobial etiology that is not fully delineated. Owing to the potential for serious sequelae, a low threshold for diagnosis and treatment is recommended. As PID has a multimicrobial etiology, including Neisseria gonorrhoeae, Chlamydial trachomatis and anaerobic and mycoplasmal bacteria, treatment of PID should consist of a broad spectrum antiobiotic regimen. Recent treatment trials have focused on shorter duration regimens, such as azithromycin, and monotherapies including ofloxacin, but data are sparse. Research comparing sequelae development by differing antimicrobial regimens is extremely limited, but will ultimately shape future treatment guidelines.